Home › Teva Advances Most in Three Weeks on FDA Panel: Tel Aviv Mover
 

Keywords :   


Teva Advances Most in Three Weeks on FDA Panel: Tel Aviv Mover

2013-06-10 05:07:15| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, advanced the most in three weeks on prospects the drugmaker will begin selling its generic diabetes pill in the U.S. Shares of the Petach Tikva, Israel-based company gained 2.2 percent, the most since May 16, to 142.2 shekels, or $39.41, at the close in Tel Aviv, ... (more)

Tags: tel weeks panel advances

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Tropical Storm Leslie Public Advisory Number 10
More »